Denali Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Sell |
31,700
-2,400
| -7% | -$58.2K | 0.08% | 197 |
|
|
2025
Q1 | $864K | Sell |
34,100
-3,000
| -8% | -$76K | 0.1% | 185 |
|
|
2024
Q4 | $984K | Buy |
37,100
+4,200
| +13% | +$111K | 0.1% | 178 |
|
|
2024
Q3 | $952K | Buy |
32,900
+1,300
| +4% | +$37.6K | 0.1% | 175 |
|
|
2024
Q2 | $884K | Buy |
31,600
+2,400
| +8% | +$67.2K | 0.24% | 92 |
|
|
2024
Q1 | $810K | Buy |
29,200
+3,100
| +12% | +$86K | 0.24% | 98 |
|
|
2023
Q4 | $751K | Buy |
26,100
+2,600
| +11% | +$74.9K | 0.23% | 102 |
|
|
2023
Q3 | $779K | Buy |
23,500
+3,700
| +19% | +$123K | 0.27% | 93 |
|
|
2023
Q2 | $726K | Hold |
19,800
| – | – | 0.26% | 102 |
|
|
2023
Q1 | $808K | Buy |
+19,800
| New | +$808K | 0.34% | 76 |
|
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$215K | – | 404 |
|
|
2021
Q3 | $215K | Buy |
+5,000
| New | +$215K | 0.09% | 152 |
|
|
2020
Q2 | – | Sell |
-13,386
| Closed | -$415K | – | 375 |
|
|
2020
Q1 | $415K | Sell |
13,386
-209,219
| -94% | -$6.49M | 0.09% | 166 |
|
|
2019
Q4 | $8.28M | Buy |
+222,605
| New | +$8.28M | 1.17% | 32 |
|